Franke, A., Teyssen, S., Harder, H., Singer, M. V. (Jul, 2004). Effect of ethanol and some ethanolic beverages on gastric emptying in humans. Scand J Gastroenterol, 39(7): 638−644.
Freitas, R. A. (1999). Nanomedicine, Volume 1: Basic capabilities. Landes Bioscience: Georgetown, TX.
HMP1013. A randomised, open-label, single dose, 4 way crossover study of the effects of varying doses of ethanol on the pharmacokinetic characteristics of 12 mg hydromorphone hydrochloride extended release capsules (PalladoneTM) in two groups (fed and fasted) of healthy volunteers. Data in house, Purdue Pharma (US).
HMP1014. A randomised, open-label, single dose, 7-treatment, 4-period, Incomplete block crossover study in healthy male subjects to determine the effect of ethanol administration at varying times on the pharmacokinetics of hydromorphone hydrochloride (PalladoneTM)12 mg. Data in house, Purdue Pharma (US).
Levitt, M. D., Li, R., Demaster, E. G., Elson, M., Furne, J. Levitt, D. G. (Oct, 1997). Use of measurements of ethanol absorption from stomach and intestine to assess human ethanol metabolism. Am J Physiol., 273(4 Pt 1): G951−G957.
Meyer, R. J., Hussein, A. S. Awareness Topic: Mitigating the risks of ethanol induced dose dumping from oral sustained/controlled release dosage forms. FDA’s ACPS Meeting, October 2005.
Oneta, C. M., Simanowski, U. A., Martinez, M., Allali-Hassani, A., Pares, X., Homann, N., Conradt, C., Waldherr, R., Fiehn, W., Courelle, C., Seitz, H. K. (Nov, 1998). First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying. Gut. 43(5): 612−619.